Skip to content
← Back to this collection

PUBLICATIONS · 16145047

Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: updated findings from NCIC CTG MA.17.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Natl Cancer Inst
Publication date
2005 Sep 7
First author
Goss PE

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Natl Cancer Inst. 2006 Aug 16;98(16):1162; author reply 1162-3. doi: 10.1093/jnci/djj323.
    note
    Source null
    related pmid
    16912269
    relationship
    Comment in

Authors and identifiers

  1. name
    Goss PE
    type
    Author
  2. name
    Ingle JN
    type
    Author
  3. name
    Martino S
    type
    Author
  4. name
    Robert NJ
    type
    Author
  5. name
    Muss HB
    type
    Author
  6. name
    Piccart MJ
    type
    Author
  7. name
    Castiglione M
    type
    Author
  8. name
    Tu D
    type
    Author
  9. name
    Shepherd LE
    type
    Author
  10. name
    Pritchard KI
    type
    Author
  11. name
    Livingston RB
    type
    Author
  12. name
    Davidson NE
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Goss PE
    type
    Author
  2. name
    Ingle JN
    type
    Author
  3. name
    Martino S
    type
    Author
  4. name
    Robert NJ
    type
    Author
  5. name
    Muss HB
    type
    Author
  6. name
    Piccart MJ
    type
    Author
  7. name
    Castiglione M
    type
    Author
  8. name
    Tu D
    type
    Author
  9. name
    Shepherd LE
    type
    Author
  10. name
    Pritchard KI
    type
    Author
  11. name
    Livingston RB
    type
    Author
  12. name
    Davidson NE
    type
    Author
bibliography ids
  1. nci-bib-b41362bd3a88cb947dbb04c4
book metadata
content sha256
70153549bad84ad18b08cb79303836c981fb2238f10cef6b0240054cf81e77ae
document type
citation
dois
  1. 10.1093/jnci/dji250
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:16145047
immutable id
pubmed:16145047@70153549bad84ad18b08cb79303836c981fb2238f10cef6b0240054cf81e77ae
journal
abbreviation
J Natl Cancer Inst
issn electronic
1460-2105
issn print
0027-8874
issue
17
name
Journal of the National Cancer Institute
nlm unique id
7503089
pages
1262-71
volume
97
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Natl Cancer Inst. 2006 Aug 16;98(16):1162; author reply 1162-3. doi: 10.1093/jnci/djj323.
    note
    Source null
    related pmid
    16912269
    relationship
    Comment in
outcomes validated
false
pmid
16145047
provenance
batch id
acd1a19ec1fd03e5b423
provider
NCBI PubMed ESummary
record sha256
e8a76e96955edd4b2247772f72f81550d7b637d7a8ace0d3fea1df3e35efad8b
response sha256
06f2789b1faf1384eea463ec33b6ace6458084d0e39588df6f3b23cecac27647
retrieved at
2026-09-09T23:46:01.895425+00:00
publication date
display
2005 Sep 7
precision
day
year
2005
publication types
  1. Clinical Trial
  2. Journal Article
  3. Randomized Controlled Trial
  4. Research Support, N.I.H., Extramural
  5. Research Support, Non-U.S. Gov't
  6. Research Support, U.S. Gov't, P.H.S.
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/16145047/
title
Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: updated findings from NCIC CTG MA.17.

Preserved source evidence · Not medical advice